Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. (Q51888776)
Jump to navigation
Jump to search
scientific article published on 8 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. |
scientific article published on 8 April 2008 |
Statements
1 reference
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. (English)
1 reference
1 reference
1 reference
Guido Reifenberger
1 reference
Jörg Felsberg
1 reference
Robert Charles Janzer
1 reference
Marie-France Hamou
1 reference
Annie-Claire Diserens
1 reference
Roger Stupp
1 reference
Thierry Gorlia
1 reference
Christine Marosi
1 reference
Harald Heinzl
1 reference
Johannes A Hainfellner
1 reference
8 April 2008
1 reference
1 reference
18
1 reference
4
1 reference
520-532
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference